Lowering SREBP2 levels in an Alzheimer’s disease mouse model results in reduced production of amyloid-beta, a major contributor to Alzheimer’s disease progression. The gene discussed is SREBF2; the disease is early-onset autosomal dominant Alzheimer disease.